Press Releases March 31, 2026 08:00 PM

QCR Holdings, Inc. to Report First Quarter 2026 Financial Results

QCR Holdings Announces Upcoming Q1 2026 Earnings Release and Conference Call

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
QCRH

QCR Holdings, Inc. plans to release its first quarter 2026 financial results on April 22, 2026, followed by a conference call and webcast discussion on April 23, 2026. The company operates multi-bank holding subsidiaries serving several Midwestern communities with banking, trust, and wealth management services, holding $9.6 billion in assets as of the end of 2025.

QCR Holdings, Inc. to Report First Quarter 2026 Financial Results
QCRH
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • QCR Holdings will release Q1 2026 financial results after market close on April 22, 2026.
  • A conference call and webcast to discuss the results will be held on April 23, 2026, accessible to shareholders and analysts.
  • The company operates through multiple banks in Iowa, Missouri, and Illinois, providing full-service banking and wealth management with $9.6 billion in assets.
  • The banking sector and regional banking markets in the Midwest are primarily impacted by this announcement.

MOLINE, Ill., April 01, 2026 (GLOBE NEWSWIRE) -- QCR Holdings, Inc. (NASDAQ: QCRH) (“QCRH” or the “Company”) announced today that its first quarter ended March 31, 2026 financial results will be released after the market closes on Wednesday, April 22, 2026. The Company will host a conference call and webcast the next day, Thursday, April 23, 2026, at 10:00 a.m. Central Time to discuss the results. Shareholders, analysts, and other interested parties are invited to join.

Teleconference
Dial-in information for the call is 888-346-9286 (international 412-317-5253). Participants should request to join the QCR Holdings, Inc. call. The event will be archived and available for replay through April 30, 2026. The replay access information is 855-669-9658 (international 412-317-0088); access code 8231225.

Webcast
A webcast of the teleconference can be accessed at the Company’s News and Events page at www.qcrh.com. An archived version of the webcast will be available at the same location shortly after the live event has ended.

About Us
QCR Holdings, Inc., headquartered in Moline, Illinois, is a relationship-driven, multi-bank holding company serving the Quad Cities, Cedar Rapids, Cedar Valley, Des Moines/Ankeny and Springfield communities through its wholly owned subsidiary banks. The banks provide full-service commercial and consumer banking and trust and wealth management services. Quad City Bank & Trust Company, based in Bettendorf, Iowa, commenced operations in 1994, Cedar Rapids Bank & Trust Company, based in Cedar Rapids, Iowa, commenced operations in 2001, Community State Bank, based in Ankeny, Iowa, was acquired by the Company in 2016, and Guaranty Bank, based in Springfield, Missouri, was acquired by the Company in 2018. Additionally, the Company serves the Waterloo/Cedar Falls, Iowa community through Community Bank & Trust, a division of Cedar Rapids Bank & Trust Company. The Company has 36 locations in Iowa, Missouri, and Illinois. As of December 31, 2025, the Company had $9.6 billion in assets, $7.2 billion in loans and $7.4 billion in deposits. For additional information, please visit the Company’s website at www.qcrh.com.

Contact
Nick W. Anderson                                                        
Chief Financial Officer                                
(309) 743-7707 
[email protected]                                                                


Risks

  • The article does not provide any specific financial guidance or forecasts, creating uncertainty about upcoming performance.
  • Economic or local market conditions could affect the company's financial results and future outlook.
  • As a regional bank holding company, operational risks include competition, interest rate changes, and regulatory impacts relevant to the banking sector.

More from Press Releases

Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026 ROMA Green Finance Establishes Dedicated Artificial Intelligence and High-Performance Computing Infrastructure Investment Vertical Jun 12, 2026